BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2008
View Archived Issues
FMP2.1/AS02A immunogenic in malaria-experienced population
Read More
Preclinical profile of Pfizer's novel NOP receptor agonist
Read More
EpiCept reports positive results from phase II Neuracept trial of EpiCept NP-1 for DPN
Read More
Calibrant enters collaboration with Yale University for ovarian and breast cancer drug targets
Read More
FDA approves BioMarck's plans for phase II trial of BIO-11006 for COPD
Read More
ArQule receives milestone payment from Kyowa Hakko relating to ARQ-197
Read More
Nile Therapeutics initiates dosing in phase Ib clinical study of CD-NP for heart failure
Read More
Novo Nordisk pays milestone payment to Neose for factor VIII program for hemophilia A
Read More
HE-3235 active in hormone-independent prostate cancer models
Read More
FDA advisory committee supports approval of Zyprexa long-acting injection for schizophrenia
Read More
Lovastatin safe in children with neurofibromatosis type 1 / News in Context
Read More
FDA grants orphan drug designation to ARG-201 for diffuse systemic sclerosis
Read More
Spectrum initiates phase I trial for SPI-1620 as an adjunct to cancer chemotherapy
Read More
Metabonomic study shows different brain chemical profile in bipolar disorder
Read More
Enanta describes new remedial option for HCV infection in a recent patent
Read More
New treatment alternative for glaucoma imparted in recent Allergan patent
Read More
Novel therapeutic agents for HIV infection disclosed in patent literature
Read More
InNexus announces preliminary results from animal study of DXL-625 for NHL
Read More
NIAID reports negative results from phase III HPTN-039 clinical study of aciclovir
Read More
FDA extends NDA action date for Entereg
Read More
Newron acquires U.K. biopharmaceutical Hunter-Fleming
Read More
FDA inquiry into Allergan's Botox dose regimen relates to medical not cosmetic uses
Read More
VGX Pharmaceuticals files IND for DNA therapy to treat cancer cachexia and anemia
Read More
Transdel submits to FDA phase III clinical study proposal for Ketotransdel in acute pain
Read More
